Search Results 1741-1750 of 21405 for anti-TNF drugs

1. Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... anti-hypertensive medication must be on a stable anti-hypertensive regimen.

2. Sulfonamide (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Sulfonamides, or sulfa medicines, belong to the family of medicines called anti-infectives. Sulfonamide ophthalmic preparations are used to treat infections ...

3. Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... Anti-cholinergic agents (e.g, dicyclomine, hyoscyamine, propantheline) ...

4. Analgesic Combination, Acetaminophen/Salicylate (Oral Route) Description and Brand Names - Mayo Clinic

   Acetaminophen and salicylate combination medicines relieve pain and reduce fever. They may be used to relieve occasional pain caused by mild inflammation or ...

5. Hydrochlorothiazide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

6. Teriflunomide (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

   ... therapy and previously treated with at least 2 regimens including at least two anti-HER2 agents;; Patients who have failed therapy with at least two anti ...

8. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

   Patients with known human immunodeficiency virus (HIV) on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...

9. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... Received < 2 prior systemic anti-cancer therapy including investigational agents ...

10. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Participation in other drug clinical trials (participation in COVID-19 anti-viral trials may be permitted if ...